Ivabradine May Reduce HF Readmissions MedPage Today Ivabradine (Procoralan) added to standard heart failure therapy reduced HF readmissions by a third in patients with systolic heart failure compared with patients on standard treatment, according to a post hoc analysis of data from the SHIFT trial. In ... |
